View in EDS HTML Full Text PDF Full Text

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

Saved in:
Bibliographic Details
Title: Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Authors: Palomo L; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain., Ibáñez M; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, València, Spain., Abáigar M; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain., Vázquez I; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Álvarez S; NIMGenetics, Genómica y Medicina, S.L., Madrid, Spain., Cabezón M; Haematology Service, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Tazón-Vega B; Department of Haematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Rapado I; Haematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.; Centro de investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain., Fuster-Tormo F; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain., Cervera J; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Benito R; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain., Larrayoz MJ; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Cigudosa JC; NIMGenetics, Genómica y Medicina, S.L., Madrid, Spain., Zamora L; Haematology Service, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Valcárcel D; Department of Haematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Cedena MT; Haematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.; Centro de investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain., Acha P; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain., Hernández-Sánchez JM; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain.; University of Salamanca (USAL), Salamanca, Spain., Fernández-Mercado M; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Advanced Genomics Laboratory, Centre for Applied Medical Research (CIMA), University of Navarra, Haemato-Oncology, Pamplona, Spain.; Biomedical Engineering Department, School of Engineering, University of Navarra, San Sebastian, Spain., Sanz G; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain., Hernández-Rivas JM; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain.; University of Salamanca (USAL), Salamanca, Spain.; Hospital Universitario de Salamanca, Salamanca, Spain., Calasanz MJ; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Solé F; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain., Such E; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, València, Spain.
Corporate Authors: Spanish Group of MDS (GESMD)
Source: British journal of haematology [Br J Haematol] 2020 Mar; Vol. 188 (5), pp. 605-622. Date of Electronic Publication: 2019 Oct 16.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31621063
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Palomo+L%22">Palomo L</searchLink>; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain.<br /><searchLink fieldCode="AU" term="%22Ibáñez+M%22">Ibáñez M</searchLink>; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, València, Spain.<br /><searchLink fieldCode="AU" term="%22Abáigar+M%22">Abáigar M</searchLink>; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Vázquez+I%22">Vázquez I</searchLink>; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Álvarez+S%22">Álvarez S</searchLink>; NIMGenetics, Genómica y Medicina, S.L., Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cabezón+M%22">Cabezón M</searchLink>; Haematology Service, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Tazón-Vega+B%22">Tazón-Vega B</searchLink>; Department of Haematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rapado+I%22">Rapado I</searchLink>; Haematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.; Centro de investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fuster-Tormo+F%22">Fuster-Tormo F</searchLink>; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain.<br /><searchLink fieldCode="AU" term="%22Cervera+J%22">Cervera J</searchLink>; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Benito+R%22">Benito R</searchLink>; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+MJ%22">Larrayoz MJ</searchLink>; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Cigudosa+JC%22">Cigudosa JC</searchLink>; NIMGenetics, Genómica y Medicina, S.L., Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Zamora+L%22">Zamora L</searchLink>; Haematology Service, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Valcárcel+D%22">Valcárcel D</searchLink>; Department of Haematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cedena+MT%22">Cedena MT</searchLink>; Haematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.; Centro de investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Acha+P%22">Acha P</searchLink>; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández-Sánchez+JM%22">Hernández-Sánchez JM</searchLink>; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain.; University of Salamanca (USAL), Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández-Mercado+M%22">Fernández-Mercado M</searchLink>; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Advanced Genomics Laboratory, Centre for Applied Medical Research (CIMA), University of Navarra, Haemato-Oncology, Pamplona, Spain.; Biomedical Engineering Department, School of Engineering, University of Navarra, San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Sanz+G%22">Sanz G</searchLink>; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández-Rivas+JM%22">Hernández-Rivas JM</searchLink>; Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Centre (IBMCC-CIC; Univ. of Salamanca-CSIC), Salamanca, Spain.; University of Salamanca (USAL), Salamanca, Spain.; Hospital Universitario de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Calasanz+MJ%22">Calasanz MJ</searchLink>; Haematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Solé+F%22">Solé F</searchLink>; Josep Carreras Leukaemia Research Institute, ICO Badalona-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Sadalona, Spain.<br /><searchLink fieldCode="AU" term="%22Such+E%22">Such E</searchLink>; Department of Haematology, Hospital Universitari i Politècnic La Fe, València, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, València, Spain.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Spanish+Group+of+MDS+%28GESMD%29%22">Spanish Group of MDS (GESMD)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2020 Mar; Vol. 188 (5), pp. 605-622. <i>Date of Electronic Publication: </i>2019 Oct 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31621063
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.16175
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 605
    Titles:
      – TitleFull: Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Palomo L
      – PersonEntity:
          Name:
            NameFull: Ibáñez M
      – PersonEntity:
          Name:
            NameFull: Abáigar M
      – PersonEntity:
          Name:
            NameFull: Vázquez I
      – PersonEntity:
          Name:
            NameFull: Álvarez S
      – PersonEntity:
          Name:
            NameFull: Cabezón M
      – PersonEntity:
          Name:
            NameFull: Tazón-Vega B
      – PersonEntity:
          Name:
            NameFull: Rapado I
      – PersonEntity:
          Name:
            NameFull: Fuster-Tormo F
      – PersonEntity:
          Name:
            NameFull: Cervera J
      – PersonEntity:
          Name:
            NameFull: Benito R
      – PersonEntity:
          Name:
            NameFull: Larrayoz MJ
      – PersonEntity:
          Name:
            NameFull: Cigudosa JC
      – PersonEntity:
          Name:
            NameFull: Zamora L
      – PersonEntity:
          Name:
            NameFull: Valcárcel D
      – PersonEntity:
          Name:
            NameFull: Cedena MT
      – PersonEntity:
          Name:
            NameFull: Acha P
      – PersonEntity:
          Name:
            NameFull: Hernández-Sánchez JM
      – PersonEntity:
          Name:
            NameFull: Fernández-Mercado M
      – PersonEntity:
          Name:
            NameFull: Sanz G
      – PersonEntity:
          Name:
            NameFull: Hernández-Rivas JM
      – PersonEntity:
          Name:
            NameFull: Calasanz MJ
      – PersonEntity:
          Name:
            NameFull: Solé F
      – PersonEntity:
          Name:
            NameFull: Such E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2020 Mar
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 188
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1